Interestingly, the efficacy of IL-33 in this infection model (and others) seems to be highly time-dependent, with administration of exogenous IL-33 at late time points post-infection being ineffective in promoting type 2 responses that would otherwise resolve infection. Here, IL33 is linked to infection.